MCM
TECX

Monimus Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Monimus Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$967K Buy
28,143
+1,390
+5% +$40.8K 0.22% 55
2026
Q1 		$827K Buy
26,753
+159
+0.6% +$3.91K 0.23% 53
2025
Q4 		$555K Buy
26,594
+2,700
+11% +$50.2K 0.37% 53
2025
Q3 		$375K Hold
23,894
– – 0.23% 58
2025
Q2 		$475K Buy
23,894
+5,433
+29% +$110K 0.35% 50
2025
Q1 		$327K Buy
+18,461
New +$602K 0.28% 44

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Monimus Capital Management's TECX Position: Q2 2026 in Review

Monimus Capital Management increased its Tectonic Therapeutic (TECX) stake by 5.2% in Q2 2026, buying an estimated $40.8K and bringing the position to 28,143 shares worth $967K. The position accounts for 0.22% of the portfolio, ranked #55.

Monimus Capital Management first reported a position in TECX in Q1 2025 and has held it in 6 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Monimus Capital Management held 28,143 shares of Tectonic Therapeutic worth $967K as of Q2 2026.
  • Monimus Capital Management bought 1,390 Tectonic Therapeutic shares in Q2 2026, an estimated $40.8K.
  • Tectonic Therapeutic made up 0.22% of Monimus Capital Management's portfolio in Q2 2026, its #55 holding.
  • Monimus Capital Management first reported a position in Tectonic Therapeutic in Q1 2025 and has held it in 6 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Monimus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.